Roy Wiesner - Profile and Investment Details

Investor Profile

Roy Wiesner is a Angel Group, Venture Capital, Private Equity Firm based in Israel with a diverse investment portfolio that includes companies such as CuResponse, Karius, AbSci, CartiHeal, Zebra Medical Vision, Mammoth Biosciences, DayTwo, AtaCor Medical, MiNA Therapeutics, Ibex Medical Analytics, NanoGhosts, Theranica, Scipher Medicine, Seer, Mobilion Systems, Nobio, MDClone, Medial EarlySign, SOPHiA GENETICS, Vocalis Health, Viracta Therapeutics, Ayala Pharmaceuticals, Igentify, Nectin Therapeutics, Apos Therapy. Over time, Roy Wiesner has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Roy Wiesner is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, Alternative Medicine, Medical Testing, Investment Management, Life Science, Artificial Intelligence (AI), Israel-based Startups, Biotech, Analytics, Medical Device, Bioinformatics, Healthcare, Biotechnology, Genomics, Health IT, Financial Services, Health Diagnostics, Digital Health, Medical, Big Data, Therapeutics, Media and Entertainment, Machine Learning, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Roy Wiesner, as their portfolio suggests a familiarity and interest in this area.

Understanding Roy Wiesner’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.